Airfinity launches new COVID-19 Vaccine Supply and Production Platform

Posted on Aug 18, 2021

Airfinity's new Supply and Production Platform provides country level views of the entire COVID-19 vaccine market. This includes independent forecasts on 2021-2022 production and revenue.

Access real-time data on the number of doses that have been produced, delivered and exported for each vaccine and country. Users can also explore the different sub-suppliers for key vaccine ingredients and materials, and how this could impact future production lines.

Whether you're wanting to monitor existing supply chains, identify opportunities for commercial investment or inform global policy recommendations, Airfinity's platform provides decision makers with the tools to move faster and more efficiently.

For more information and to receive a free walkthrough of the platform, get in touch here.

Document Library